ID: ALA3950285

Max Phase: Preclinical

Molecular Formula: C23H18F8N4O7

Molecular Weight: 614.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)[C@H](NC(=O)C(=O)Nc1c(F)c(F)nc(F)c1F)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F

Standard InChI:  InChI=1S/C23H18F8N4O7/c1-6(2)16(33-22(40)23(41)34-17-14(28)19(30)35-20(31)15(17)29)21(39)32-9(4-11(37)38)10(36)5-42-18-12(26)7(24)3-8(25)13(18)27/h3,6,9,16H,4-5H2,1-2H3,(H,32,39)(H,33,40)(H,37,38)(H,34,35,41)/t9-,16-/m0/s1

Standard InChI Key:  ZJEAAPUACVGAGQ-FVMDXXJSSA-N

Associated Targets(Human)

Caspase-3 3632 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Caspase-6 1213 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Caspase-8 1006 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Caspase-1 361 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 614.40Molecular Weight (Monoisotopic): 614.1048AlogP: 1.88#Rotatable Bonds: 11
Polar Surface Area: 163.79Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.68CX Basic pKa: CX LogP: 2.90CX LogD: -0.44
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.13Np Likeness Score: -0.64

References

1.  (2007)  C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases, 

Source